Abnormal Igf2 gene in Prague hereditary hypertriglyceridemic rats: its relation to blood pressure and plasma lipids

. 2008 Jul ; 314 (1-2) : 37-43. [epub] 20080417

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid18418699

Prague hypertriglyceridemic (HTG) rats represent a suitable model of metabolic syndrome. We have established the set of F(2) hybrids derived from HTG and Lewis progenitors to investigate the relationship between respective polymorphism(s) of Igf2 gene and blood pressure (BP) or other cardiovascular phenotypes. HTG rats had elevated systolic BP and plasma triglycerides but lower plasma cholesterol compared to Lewis rats of both genders. In males, there was higher mean arterial pressure, diastolic BP and relative heart weight in HTG than in Lewis rats. The results obtained in the total population of F(2) hybrids indicated strong segregation of Igf2 genotype with plasma triglycerides. There was no segregation of Igf2 genotype with any BP component except BP changes occurring after the blockade of either renin-angiotensin system (RAS) or NO synthase. When F(2) population was analyzed according to gender, male F(2) progeny homozygous for HTG Igf2 allele had significantly higher plasma triglycerides and greater BP changes after NO synthase blockade than those homozygous for Lewis allele. On the contrary, male F(2) progeny homozygous for HTG Igf2 allele had significantly lower plasma cholesterol and smaller BP changes after RAS blockade. PCR analysis of Igf2 gene by using of microsatelite D1Mgh22 has shown polymorphism between HTG and Lewis rats. Sequence analysis of cDNA revealed insertion of 14 nucleotides in HTG gene. In conclusion, polymorphism in Igf2 gene may be responsible for differences in lipid metabolism between HTG and Lewis rats. It remains to determine how these abnormalities could be involved in BP regulation by particular vasoactive systems.

Zobrazit více v PubMed

Transplant Proc. 1990 Dec;22(6):2579 PubMed

J Clin Endocrinol Metab. 1994 Jul;79(1):230-2 PubMed

Physiol Genomics. 1999 Nov 11;1(3):119-25 PubMed

J Clin Invest. 1989 Apr;83(4):1404-8 PubMed

Hypertension. 1997 Sep;30(3 Pt 2):636-40 PubMed

Eur J Clin Invest. 1999 Sep;29(9):758-69 PubMed

Lancet. 2002 May 18;359(9319):1740-5 PubMed

Am J Hum Genet. 1999 Aug;65(2):397-412 PubMed

Biochem Biophys Res Commun. 1997 Jun 18;235(2):343-8 PubMed

Physiol Res. 2004;53(3):265-71 PubMed

Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E306-14 PubMed

Circulation. 2004 Oct 12;110(15):2260-5 PubMed

Physiol Res. 2006;55(4):373-9 PubMed

BMC Endocr Disord. 2005 Jun 01;5:5 PubMed

Clin Exp Pharmacol Physiol. 1998 Dec;25(12):1004-7 PubMed

Life Sci. 1992;51(10):733-40 PubMed

Hypertension. 1999 Aug;34(2):187-91 PubMed

Cardiovasc Res. 1995 May;29(5):708-16 PubMed

Genes Dev. 1997 Dec 1;11(23):3128-42 PubMed

Clin Sci (Lond). 1998 Jan;94(1):79-85 PubMed

J Endocrinol Invest. 1999;22(5 Suppl):82-8 PubMed

Diabetes. 1994 Aug;43(8):1027-32 PubMed

Physiol Res. 1995;44(6):421-4 PubMed

Clin Sci (Lond). 2002 Mar;102(3):269-77 PubMed

Hypertension. 1997 Mar;29(3):691-9 PubMed

Physiol Genomics. 2004 Mar 12;17(1):38-47 PubMed

Hypertension. 2001 Jun;37(6):1480-5 PubMed

Cell. 1991 Feb 22;64(4):849-59 PubMed

Physiol Res. 2006;55 Suppl 1:S49-63 PubMed

J Mol Med (Berl). 2003 Jan;81(1):51-60 PubMed

Diabet Med. 2003 Jan;20(1):3-15 PubMed

Ann Epidemiol. 2006 Jul;16(7):563-71 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Research on Experimental Hypertension in Prague (1966-2009)

. 2024 Aug 31 ; 73 (Suppl 1) : S49-S66. [epub] 20240717

Hypertension after the Menopause: What Can We Learn from Experimental Studies?

. 2023 Jul 31 ; 72 (Suppl 2) : S91-S112.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...